SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
HeartSciences issued a press release on July 29, 2026 disclosing fiscal year 2026 financial results for the period ended April 30, 2026, including revenue, cash position of $1.7 million, and shareholders' equity of $0.2 million.
View raw filing on EDGAR →SciSparc's board announced a strategic decision to target the agentic AI market and establish a Scientific Advisory Board for AI and cybersecurity, representing a material shift in the company's business focus and strategic direction.
View raw filing on EDGAR →NeuroThera Labs, SciSparc's majority-owned subsidiary, completed internal validation of its proprietary quantum computing platform (CliniQuantum) for clinical data analytics, demonstrating successful validation of a quantum sampling workflow on a hybrid quantum-classical platform with potential applications to drug development and clinical trials.
View raw filing on EDGAR →The 6-K discloses that REE Automotive is in formal restructuring proceedings under Israeli insolvency law (Amendment No. 9 to the Israeli Insolvency and Economic Rehabilitation Law, 2018), with a Court-appointed Arrangement Manager overseeing operations and a stay of proceedings extended through August 16, 2026. The filing explicitly states "There can be no assurance that the proposed debt arrangement will be approved by the Court, that the required stakeholder support will be obtained, or that the restructuring will be successfully implemented." This language and the formal insolvency restructuring framework create substantial doubt about the company's ability to continue as a going concern.
View raw filing on EDGAR →SCWorx was delisted from Nasdaq on April 14, 2026 for failing to maintain the minimum bid price of $1 per share, but successfully appealed and received conditional continued listing on June 17, 2026 subject to completing a reverse stock split and achieving compliance with the bid price rule by August 28, 2026. The filing discloses the delisting event, the appeal process, and the conditions for maintaining listing—core delisting-risk disclosure. The company has received partial compliance confirmation as of July 24, 2026, but faces material uncertainty about achieving full compliance.
View raw filing on EDGAR →Jeffrey Harris was appointed to the Board of Directors as a Class II director effective July 26, 2026, filling a vacancy. While Harris previously served as CEO and founder of SpringBig before his resignation on March 31, 2025, the principal disclosed action here is his appointment to the Board. This is a material governance event involving a significant figure in the company's history returning to a leadership position.
View raw filing on EDGAR →The 6-K discloses entry into securities purchase agreements on July 17, 2026, for the issuance and sale of 20,000,000 Class A ordinary shares at $10.00 per share, generating gross proceeds of $200.0 million. The offering closed on July 29, 2026. This is a material registered equity issuance that dilutes existing shareholders and raises substantial capital for AI computing center development. The transaction meets the definition of dilutive_issuance under Item 3.02 equivalent disclosure.
View raw filing on EDGAR →The Company received a deficiency letter from Nasdaq on July 22, 2026, notifying it that its market value of listed securities (MVLS) closed below the $35 million threshold required under Nasdaq Listing Rule 5550(b)(2) for 30 consecutive business days. The Company has until January 19, 2027 to regain compliance, and failure to do so will result in delisting. This is a classic delisting-risk disclosure under Item 3.01.
View raw filing on EDGAR →The filing discloses the reconstitution of the Audit Committee following a prior board member's resignation that caused temporary non-compliance with Nasdaq Listing Rule 5605(c)(2)(A). The Company has now restored compliance by appointing four independent directors to the Audit Committee, including one financial expert. This is a governance matter addressing a listing rule compliance issue, but does not fit the specific categories of exec_departure, exec_appointment, or exec_compensation—it is a structural board/committee governance action.
View raw filing on EDGAR →Costco's discontinuation of the Company's FOCUSfactor products represents a material loss of a major customer (58% of FY2025 net revenue for over 16 years), which is an operational/commercial event with severe financial consequences. The Company explicitly states it expects a "material adverse effect" on business, operations, liquidity, and financial condition. This is a significant customer loss that does not fit the specific categories of M&A, impairment, or litigation, but clearly qualifies as a material operational event.
View raw filing on EDGAR →Purple Biotech held an Annual General Meeting on September 8, 2026, at which shareholders were asked to approve: (1) election of directors Gil Efron and Yael Margolin; (2) approval of compensation terms for Gil Efron in connection with his transition from CEO to Executive Director, Head of Corporate Development, effective August 31, 2026; and (3) adoption of an amended and restated compensation policy for executive officers and directors.
View raw filing on EDGAR →Catalyst Acquisition Corp. consummated a $200 million IPO on July 27, 2026, and entered into multiple material definitive agreements (Underwriting Agreement, Investment Management Trust Agreement, Private Placement Units Purchase Agreement, Administrative Services Agreement, and others) establishing the blank-check SPAC structure for future business combination activity.
View raw filing on EDGAR →The Company completed an unregistered private placement of 270,000 Private Placement Units to the Sponsor at $10.00 per unit ($2.7 million aggregate) pursuant to Section 4(a)(2) exemption, concurrent with the IPO closing on July 27, 2026.
View raw filing on EDGAR →Three directors—Melvin D. Lindsey, Richard W. Cook, and Christopher Heatherly—were appointed to the Board effective July 27, 2026, in connection with the IPO, with assignments to the Audit, Compensation, and Corporate Governance and Nominating committees.
View raw filing on EDGAR →Catalyst Acquisition Corp. priced and closed a $200 million IPO, with proceeds placed in a trust account pending a future business combination, establishing the company's public status and capital structure as a blank-check acquisition vehicle.
View raw filing on EDGAR →The 6-K discloses settlement of a material lawsuit filed by shareholders against the Company and Co-CEO Satoshi Kobayashi in Tokyo District Court in December 2023. The Plaintiffs originally sought USD 2.925 million in damages for alleged breach of obligation related to the IPO. On July 17, 2026, a judicial settlement was reached with a settlement payment of JPY 20 million (approximately USD 122,000) completed on July 27, 2026, and withdrawal of provisional attachments on the Company's bank accounts. This settlement of material litigation affecting a named executive and the Company's operations is material to investors.
View raw filing on EDGAR →The filing discloses the Board of Directors' declaration of a quarterly cash dividend of $0.05 per share payable on September 21, 2026 to shareholders of record on August 31, 2026. This is a routine but material dividend distribution event that would affect investor assessment of capital allocation and shareholder returns.
View raw filing on EDGAR →The 6-K discloses the results of Brenmiller Energy's Annual and Special General Meeting of Shareholders held on July 29, 2026, at which "shareholders of the Company voted upon and approved all agenda items." This is a direct disclosure of shareholder vote results, matching the `shareholder_vote_results` event type. The approval of all proposed agenda items at an annual meeting is material to investors as it confirms governance actions and any proposals put to shareholders.
View raw filing on EDGAR →The filing discloses a draw of $5,000 thousand under an unsecured promissory note dated January 30, 2024 between Constellation Acquisition Corp I and Constellation Sponsor LP, creating a direct financial obligation. While the note itself was previously established, this draw represents a new creation or increase of a direct financial obligation under Item 2.03. The funds were deposited into the trust account to extend the business combination deadline, which is material to shareholders evaluating the company's timeline and sponsor support.
View raw filing on EDGAR →House of Doge Inc.'s subsidiary Dogecoin Ventures, Inc. issued an unsecured subordinated short-term note for $1,400,000 principal to Devlin DeFrancesco on July 28, 2026, bearing 10.714% annual interest and maturing July 27, 2027, with repayment in ZONE Shares and cash.
View raw filing on EDGAR →The Company dismissed CBIZ CPAs P.C. as its independent registered public accounting firm effective July 23, 2026, and concurrently engaged Davidson & Company LLP as the new auditor, with the change revealing material weaknesses in internal controls over financial reporting including deficiencies in cash disbursement review, general ledger reconciliation, income tax controls, and cybersecurity policies.
View raw filing on EDGAR →Change Agents Corporation entered into a Business Loan and Security Agreement on July 24, 2026, creating a new direct financial obligation of $825,000 principal with total repayment of $1,188,000 due in 30 weekly installments through March 3, 2027, secured by collateral and subject to restrictive covenants.
View raw filing on EDGAR →The Company issued 360,000 shares of common stock (Commitment Shares) as consideration under a Forbearance Letter Agreement, pursuant to Section 4(a)(2) of the Securities Act of 1933, in connection with the financing transaction.
View raw filing on EDGAR →The disclosure centers on the departure of Mark DeVol, Chief Revenue Officer, Americas, effective August 1, 2026, as part of organizational restructuring and cost-reduction efforts. While the filing mentions position elimination and restructuring, the principal disclosed action is a named executive officer leaving the Company. The statement that the termination did not arise from disagreement confirms this is a straightforward departure rather than a dispute-driven event.
View raw filing on EDGAR →OS Therapies terminated its At Market Issuance Sales Agreement with B. Riley Securities and JonesTrading, eliminating access to $17.5 million in remaining authorized equity issuance capacity. While this is a termination of a material definitive agreement (Item 1.02), the core event is financial—the loss of a capital-raising mechanism—rather than a traditional M&A activity, debt issuance, or other specific financial category. The company had raised only ~$530k of the $18 million authorized, suggesting limited reliance on this facility, but the termination removes future flexibility and is material to investor assessment of the company's capital strategy.
View raw filing on EDGAR →Onconetix entered into a Securities Purchase Agreement to issue 37,812 shares of Series F convertible preferred stock for $30.2 million, with conversion rights into common stock at $0.9767 per share, and established a committed equity facility (ELOC) allowing purchases of up to $750 million in common stock. The unregistered sale relies on Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D, representing a private investment in public equity (PIPE) transaction that materially dilutes existing shareholders.
View raw filing on EDGAR →The filing discloses a nonbinding letter of intent to exchange debt and waive token rights specifically to "cure the Company's minimum stockholders' equity requirement deficiency under Nasdaq Listing Rule 5550(b)(1)" and "bring the Company back into compliance with Nasdaq's continued listing requirements." The Company previously announced this deficiency in a June 12, 2026 8-K, indicating an imminent delisting risk that the proposed transaction is designed to remediate. This is a material disclosure of the registrant's failure to satisfy a continued listing rule.
View raw filing on EDGAR →Global Mofy AI Limited entered into a Share Exchange and Investment Agreement on July 29, 2026, to acquire a 2% equity interest in Star Touch (Beijing) Technology Co., Ltd. in exchange for issuing 2,500,000 Class A ordinary shares valued at US$2 million. This constitutes a material acquisition of equity interests in a target company engaged in AI solutions, which is strategically complementary to the Company's existing operations. The transaction structure, valuation, and regulatory filing requirements indicate a discrete M&A event material to investors.
View raw filing on EDGAR →The filing discloses receipt and release of a conceptual engineering study (Hatch Report) for Ramaco's exploratory Brook Mine critical minerals project, along with a shareholder letter and press release discussing the project's latest developments. This represents a material operational/strategic milestone—the advancement of a greenfield rare earth and critical minerals extraction project from concept to initial assessment phase—but does not fit neatly into any specific event category (not M&A, not a contract, not a regulatory approval). The disclosure is material to investors assessing the company's strategic direction and project viability.
View raw filing on EDGAR →Daniel Lewis, a director of Peraso Inc., provided written notice on July 28, 2026 that he will not stand for re-election upon expiration of his current term at the 2026 annual meeting, in connection with his planned retirement. This is a director departure triggered by retirement, which is material to investors assessing board composition and governance continuity.
View raw filing on EDGAR →The filing discloses that on July 21, 2026, Fly-E Group received a delinquency notification from Nasdaq's listing qualifications staff for failure to meet the periodic filing requirement under Listing Rule 5250(c)(1). Although the company subsequently cured the deficiency by filing its Form 10-K on July 23, 2026, and the matter was closed, the initial notice of non-compliance with continued listing standards constitutes a delisting risk event material to investors. The disclosure of the delinquency notice itself—even though remedied—is the core material event being reported.
View raw filing on EDGAR →Youlife received a Nasdaq notification letter dated July 27, 2026, indicating non-compliance with the minimum bid price requirement (Rule 5550(a)(2)) because its ADS closing bid price has been below US$1.00 for 30 consecutive business days. Although the notification does not result in immediate delisting, the Company has 180 calendar days (until January 25, 2027) to regain compliance or face potential delisting. This is a classic delisting-risk disclosure under Item 3.01 equivalent, materially affecting investor assessment of the registrant's continued listing status.
View raw filing on EDGAR →The press release announces the re-appointment of Marco Leone to Nuvini's Board of Directors as an independent director, effective July 27, 2026. The appointment is material because it directly addresses a Nasdaq compliance issue: the Company had fallen out of compliance with Nasdaq Listing Rule 5605 (requiring a minimum of three independent directors on the audit committee), and Leone's election as an independent director restored that compliance. This is a governance event with direct regulatory and operational significance.
View raw filing on EDGAR →The 6-K furnishes two press releases announcing the declaration of a $0.05 per common share cash dividend payable September 22, 2026, with a record date of August 10, 2026. The second release corrects the record date from August 8. This is a straightforward dividend declaration by the Board of Directors, which is material to shareholders as it represents a return of capital and signals management confidence in the company's financial position.
View raw filing on EDGAR →Aeluma announced entry into a Letter of Intent with the U.S. Department of Commerce for up to $30 million in CHIPS and Science Act funding to advance R&D of its semiconductor manufacturing platform. This is a material strategic and operational milestone—a government funding award that would accelerate commercialization and support the company's technology development—but does not fit neatly into the specific event categories (not M&A, not debt issuance, not a dilutive equity offering per se, though equity will be issued). The funding is conditional on execution of definitive documents and milestone achievement, making it a significant operational/strategic event rather than a completed transaction or financial obligation.
View raw filing on EDGAR →This is a classic earnings release disclosure under Item 2.02. The company announced preliminary unaudited financial results for the six months ended June 30, 2026, showing consolidated revenue of approximately $80 million (57% year-over-year growth), reaffirmed 2026 guidance of $180–$200 million, and provided preliminary 2027 revenue outlook exceeding $300 million. The press release is attached as Exhibit 99.1 and constitutes the core disclosure of quarterly financial results.
View raw filing on EDGAR →The exhibit announces the results of a General Meeting held on July 29, 2026, where all four shareholder resolutions were passed. Resolutions 1 and 4 authorize a share reorganization reducing outstanding shares by a factor of 10,000 and changing the ADS ratio from 500,000:1 to 50:1, effective July 30, 2026. Resolutions 2 and 3 grant directors authority to allot shares on a non-pre-emptive basis. This is a classic shareholder vote result disclosure under Item 5.07 equivalent, and the share reorganization is material to investors' understanding of capitalization and ownership structure.
View raw filing on EDGAR →Fortinet issued a press release on July 29, 2026 reporting financial results for Q2 2026 ended June 30, 2026, disclosing revenue of $2.05 billion (26% YoY growth), GAAP EPS of $0.82 (44% YoY growth), and raising full-year 2026 revenue guidance to 19% YoY growth. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for quarterly earnings disclosures.
View raw filing on EDGAR →The filing discloses Cimpress plc's Q4 and fiscal year 2026 financial results posted on July 29, 2026, with the full earnings document furnished as Exhibit 99.1. This is a standard earnings release disclosure under Item 2.02 announcing quarterly and annual financial results, which is material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →ADAMAS TRUST, INC. disclosed quarterly financial results for the three and six months ended June 30, 2026, reporting GAAP basic earnings per share of $0.48, earnings available for distribution of $0.30 per share (up 36.4% year-over-year), book value per share of $10.16 (up 1.8% quarter-over-quarter), and adjusted book value per share of $11.05 (up 2.3% quarter-over-quarter), with detailed financial highlights and management commentary.
View raw filing on EDGAR →The exhibit announces a voluntary transfer of Collective Mining's U.S. stock exchange listing from NYSE American to Nasdaq Global Select Market, effective August 11, 2026. While framed positively as an upgrade to "the highest tier of the Nasdaq," this constitutes a material change in listing venue under Item 3.01 (Changes in and Acquisitions or Dispositions of Assets). The transfer involves delisting from one exchange and listing on another, which materially affects the registrant's capital markets presence and investor accessibility.
View raw filing on EDGAR →The exhibit is a news release announcing a cash dividend of $0.135 CDN per common share payable on September 29, 2026, to shareholders of record on September 15, 2026. This is a straightforward dividend declaration, which falls squarely within the dividend_distribution event type. The disclosure is material as it communicates a direct capital return to shareholders.
View raw filing on EDGAR →This is a news release dated July 29, 2026 disclosing Vermilion Energy's Q2 2026 operating and financial results. The exhibit presents quarterly production data (125,789 boe/d), fund flows from operations ($231 million), net earnings ($134 million), and updated full-year production guidance (121,000–123,000 boe/d). The document explicitly states "Vermilion Energy Inc. Reports Q2 2026 Results" and includes detailed financial tables and operational metrics typical of an earnings release. Material to investors as it discloses quarterly financial performance, updated guidance, and capital allocation decisions.
View raw filing on EDGAR →Blackbaud issued a press release on July 29, 2026 reporting unaudited financial results for the quarter ended June 30, 2026, with detailed GAAP and non-GAAP metrics including revenue ($290.6M, up 3.0%), operating income, net income ($35.4M), diluted EPS ($0.79), and free cash flow ($75.3M). The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for quarterly earnings disclosures.
View raw filing on EDGAR →NewMarket Corporation issued a press release on July 29, 2026 disclosing its second quarter and first half 2026 financial results, including net income of $133.8 million ($14.54 per share) for Q2 2026 and $251.8 million ($27.14 per share) for the first half, compared to prior-year periods. The filing explicitly states this is an earnings report furnished as Exhibit 99.1, which is the standard format for earnings releases under Item 2.02 of Form 8-K.
View raw filing on EDGAR →Morningstar issued a press release on July 29, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing revenue of $663.2 million (up 9.6%), operating income of $160.6 million (up 28.4%), and diluted EPS of $2.83 (up 35.4%).
View raw filing on EDGAR →Spok Holdings issued a press release on July 29, 2026, announcing second quarter 2026 financial results for the period ending June 30, 2026, including revenue, net income, adjusted EBITDA, software bookings, wireless ARPU, units in service, and updated full-year 2026 financial guidance.
View raw filing on EDGAR →On July 29, 2026, the Board declared a regular quarterly dividend of $0.3125 per share of common stock, payable on September 9, 2026.
View raw filing on EDGAR →This is a periodic interim financial report for Enel Chile S.A. covering the six-month period ended June 30, 2026. The document presents consolidated financial statements analysis, including net income (US$272 million), operating revenues (US$2,268 million), EBITDA (US$685 million), and detailed segment performance for Generation and Distribution & Grids. It is the financial report itself, not a discrete event or press release announcing results, and covers a half-year period typical of foreign private issuers' interim reporting.
View raw filing on EDGAR →This is a comprehensive earnings release for Banco Santander (Brasil) S.A.'s second quarter 2026 results (BRGAAP basis). The document discloses quarterly financial results including recurring managerial net profit of R$3.0 billion (down 20.4% QoQ and 17.6% YoY), total revenues of R$20.7 billion, net interest income of R$15.3 billion, and key performance metrics such as recurring ROAE of 12.5% and efficiency ratio of 39.3%. The filing includes detailed income statement analysis, balance sheet metrics, and strategic business performance across multiple segments, making it a material disclosure of quarterly financial results.
View raw filing on EDGAR →